These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 18471038

  • 21. Status quo--standard-of-care medical and radiation therapy for glioblastoma.
    Becker KP, Yu J.
    Cancer J; 2012; 18(1):12-9. PubMed ID: 22290252
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Immunotherapy for glioblastoma: the devil is in the details.
    Lesniak MS.
    J Clin Oncol; 2011 Aug 01; 29(22):3105; author reply 3105-6. PubMed ID: 21709193
    [No Abstract] [Full Text] [Related]

  • 24. A small proportion of glioblastoma patients are probably eligible for concomitant/adjuvant temozolomide.
    O'Toole L, Khanduri S, Gerrard GE.
    Clin Oncol (R Coll Radiol); 2007 May 01; 19(4):269. PubMed ID: 17433972
    [No Abstract] [Full Text] [Related]

  • 25. Long-term use of temozolomide: could you use temozolomide safely for life in gliomas?
    Khasraw M, Bell D, Wheeler H.
    J Clin Neurosci; 2009 Jun 01; 16(6):854-5. PubMed ID: 19303779
    [Abstract] [Full Text] [Related]

  • 26. Prolonged administration of adjuvant temozolomide improves survival in adult patients with glioblastoma.
    Darlix A, Baumann C, Lorgis V, Ghiringhelli F, Blonski M, Chauffert B, Zouaoui S, Pinelli C, Rech F, Beauchesne P, Taillandier L.
    Anticancer Res; 2013 Aug 01; 33(8):3467-74. PubMed ID: 23898121
    [Abstract] [Full Text] [Related]

  • 27. [Glioma therapy up-date].
    de la Fuente BP, Dalmau J, Rosenfeld M.
    Neurologia; 2007 Apr 01; 22(3):159-69. PubMed ID: 17364254
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.
    Mirimanoff RO, Gorlia T, Mason W, Van den Bent MJ, Kortmann RD, Fisher B, Reni M, Brandes AA, Curschmann J, Villa S, Cairncross G, Allgeier A, Lacombe D, Stupp R.
    J Clin Oncol; 2006 Jun 01; 24(16):2563-9. PubMed ID: 16735709
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Chemopotentiation by ultrafractionated radiotherapy in glioblastoma resistant to conventional therapy.
    Jahraus CD, Friedman AH.
    Tumori; 2010 Jun 01; 96(5):771-5. PubMed ID: 21302627
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A pilot study of metronomic temozolomide treatment in patients with recurrent temozolomide-refractory glioblastoma.
    Kong DS, Lee JI, Kim WS, Son MJ, Lim DH, Kim ST, Park K, Kim JH, Eoh W, Nam DH.
    Oncol Rep; 2006 Nov 01; 16(5):1117-21. PubMed ID: 17016602
    [Abstract] [Full Text] [Related]

  • 34. Long-term Results of a Survey of Prolonged Adjuvant Treatment with Temozolomide in Patients with Glioblastoma (SV3 Study).
    Rivoirard R, Falk AT, Chargari C, Guy JB, Mery B, Nuti C, Peoc'h M, Forest F, Garin C, Adjabi A, Hoarau D, Kawaye S, Almokhles H, Fournel P, Magné N.
    Clin Oncol (R Coll Radiol); 2015 Aug 01; 27(8):486-7. PubMed ID: 25963856
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study.
    Combs SE, Gutwein S, Schulz-Ertner D, van Kampen M, Thilmann C, Edler L, Wannenmacher MM, Debus J.
    Strahlenther Onkol; 2005 Jun 01; 181(6):372-7. PubMed ID: 15925979
    [Abstract] [Full Text] [Related]

  • 37. Long-term outcomes in children with glioblastoma.
    Song KS, Phi JH, Cho BK, Wang KC, Lee JY, Kim DG, Kim IH, Ahn HS, Park SH, Kim SK.
    J Neurosurg Pediatr; 2010 Aug 01; 6(2):145-9. PubMed ID: 20672935
    [Abstract] [Full Text] [Related]

  • 38. Prophylactic radiotherapy for glioblastoma in the elderly.
    Tartarone A, Ardito R, Romano C.
    N Engl J Med; 2007 Jul 12; 357(2):196; author reply 196. PubMed ID: 17626310
    [No Abstract] [Full Text] [Related]

  • 39. Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma.
    Chamberlain MC, Glantz MJ, Chalmers L, Van Horn A, Sloan AE.
    J Neurooncol; 2007 Mar 12; 82(1):81-3. PubMed ID: 16944309
    [Abstract] [Full Text] [Related]

  • 40. Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens: is the survival really so impressive?: in regard to Combs et al. (Int J Radiat Oncol Biol Phys 2008;71:999-1005).
    Jalali R.
    Int J Radiat Oncol Biol Phys; 2008 Dec 01; 72(5):1622; author reply 1622-3. PubMed ID: 19028293
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.